321 related articles for article (PubMed ID: 9591854)
1. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy.
Allen GC; Tiu C; Koike K; Ritchey AK; Kurs-Lasky M; Wax MK
Otolaryngol Head Neck Surg; 1998 May; 118(5):584-8. PubMed ID: 9591854
[TBL] [Abstract][Full Text] [Related]
2. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
3. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
Weissenstein A; Deuster D; Knief A; Zehnhoff-Dinnesen AA; Schmidt CM
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
[TBL] [Abstract][Full Text] [Related]
4. Effects of changes in dynamic characteristics of the middle ear on transient-evoked otoacoustic emissions.
Spirić S; Spirić P; Vranjes D; Aleksić A
Med Pregl; 2011; 64(9-10):439-42. PubMed ID: 22097107
[TBL] [Abstract][Full Text] [Related]
5. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Dinopoulou D; Vossinakis I; Tsakanikos M; Douniadakis D
Int J Pediatr Otorhinolaryngol; 1999 Nov; 50(3):177-84. PubMed ID: 10595663
[TBL] [Abstract][Full Text] [Related]
6. The use of transient evoked otoacoustic emissions as a hearing screen following grommet insertion.
Dale OT; McCann LJ; Thio D; Wells SC; Drysdale AJ
J Laryngol Otol; 2011 Jul; 125(7):692-5. PubMed ID: 21524331
[TBL] [Abstract][Full Text] [Related]
7. [Hearing loss caused by high dose carboplatin therapy].
Lautermann J; Adamczyk M; ten Cate WJ; Kloke O
Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.
Riga M; Psarommatis I; Korres S; Lyra Ch; Papadeas E; Varvutsi M; Ferekidis E; Apostolopoulos N
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1003-8. PubMed ID: 16359737
[TBL] [Abstract][Full Text] [Related]
9. Evoked otoacoustic emissions in infant hearing screening.
Decreton SJ; Hanssens K; De Sloovere M
Int J Pediatr Otorhinolaryngol; 1991 May; 21(3):235-47. PubMed ID: 1869377
[TBL] [Abstract][Full Text] [Related]
10. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
11. Click- and tone-burst-evoked otoacoustic emissions in normally hearing ears and in ears with high-frequency sensorineural hearing loss.
Hauser R; Probst R; Löhle E
Eur Arch Otorhinolaryngol; 1991; 248(6):345-52. PubMed ID: 1930984
[TBL] [Abstract][Full Text] [Related]
12. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
Prieve BA; Calandruccio L; Fitzgerald T; Mazevski A; Georgantas LM
Ear Hear; 2008 Aug; 29(4):533-42. PubMed ID: 18469719
[TBL] [Abstract][Full Text] [Related]
13. Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents.
Groh D; Pelanova J; Jilek M; Popelar J; Kabelka Z; Syka J
Hear Res; 2006 Feb; 212(1-2):90-8. PubMed ID: 16364580
[TBL] [Abstract][Full Text] [Related]
14. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
[TBL] [Abstract][Full Text] [Related]
15. Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.
Garinis AC; Keefe DH; Hunter LL; Fitzpatrick DF; Putterman DB; McMillan GP; Gold JA; Feeney MP
Ear Hear; 2018; 39(1):69-84. PubMed ID: 28708814
[TBL] [Abstract][Full Text] [Related]
16. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
[TBL] [Abstract][Full Text] [Related]
17. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
18. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity.
Hotz MA; Harris FP; Probst R
Laryngoscope; 1994 Sep; 104(9):1130-4. PubMed ID: 8072361
[TBL] [Abstract][Full Text] [Related]
19. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
[TBL] [Abstract][Full Text] [Related]
20. Auditory steady-state responses to bone conduction stimuli in children with hearing loss.
Swanepoel de W; Ebrahim S; Friedland P; Swanepoel A; Pottas L
Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1861-71. PubMed ID: 18963045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
